Johnson & Johnson (JNJ)

128.80
1.89 1.45
NYSE : Health Technology
Prev Close 130.69
Open 128.20
Day Low/High 127.01 / 129.50
52 Wk Low/High 118.62 / 148.99
Volume 10.54M
Avg Volume 9.33M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 350.51B
EPS 0.50
P/E Ratio 221.51
Div & Yield 3.60 (2.74%)

Latest News

3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street

3 Things to Know at Market Close: Jamie Dimon's the King of Wall Street

Here's what you're missing on TheStreet.

Johnson & Johnson Tops Q4 Earnings Estimate, Sees 2019 Sales Near $81 Billion

Johnson & Johnson Tops Q4 Earnings Estimate, Sees 2019 Sales Near $81 Billion

Johnson & Johnson posted stronger-than-expected fourth quarter earnings Tuesday and forecast a modest increase in full year sales for 2019 that would take its top line past $81 billion.

Dow Sinks as Global Growth Warnings Rattle Wall Street, Nasdaq Tumbles Over 2%

Dow Sinks as Global Growth Warnings Rattle Wall Street, Nasdaq Tumbles Over 2%

The Dow Jones Industrial Average slumps Tuesday after the blue-chip index had closed higher for four straight sessions.

Jim Cramer: What Are We to Make of Today's Market Decline?

Jim Cramer: What Are We to Make of Today's Market Decline?

Is it a retest based on the damage the Fed has already done, the result of a breakdown in trade talks or a sign of a slowing global economy?

How to Play Johnson & Johnson Now That Earnings Are Out

How to Play Johnson & Johnson Now That Earnings Are Out

There's a lot of runway left to adjust guidance numbers moving forward.

Is This Payment Technology Provider a Takeover Target?

One firm argues that the best option for USA Technologies is to be sold.

Trimming Amgen and Downgrading Our Rating

Part of our decision is based on portfolio management.

My Greatest Concern About Procter & Gamble Heading Into Earnings

My Greatest Concern About Procter & Gamble Heading Into Earnings

Volatility appears to be the most attractive play during the early portion of earnings season.

Video: Jim's Daily Rundown for Tuesday

Jim discusses Johnson & Johnson's quarter, recaps Schlumberger's quarter, what he's looking for when Comcast and Abbott Labs report earnings, and more!

Jim Cramer Says That Earnings Could Give Johnson & Johnson a Band-Aid

Jim Cramer Says That Earnings Could Give Johnson & Johnson a Band-Aid

Here's what Jim Cramer thinks of the Johnson & Johnson earnings.

Jim Cramer's High Expectations for Intel's Earnings Report

Jim Cramer's High Expectations for Intel's Earnings Report

Jim Cramer weighs in on Davos, earnings season, Johnson & Johnson and Elliott's stake in eBay.

Two Sticking Points With Johnson & Johnson: Guidance and Litigation Expense

Two Sticking Points With Johnson & Johnson: Guidance and Litigation Expense

While the ongoing litigation could be seen as a deterrent to investment, I think the more interesting story is its upcoming AFib detection study with Apple.

Johnson & Johnson Fourth-Quarter Results Top Expectations

Critics will point to a tepid 2019 outlook, but management is typically conservative with forecasts and the sell-side consensus was likely too high to begin with.

Jim Cramer on Johnson & Johnson, China and Earnings

Jim Cramer on Johnson & Johnson, China and Earnings

Johnson & Johnson, China and what to expect from earnings are just some of the topics Jim Cramer will be discussing live at 10 A.M.

Johnson & Johnson: How the Stock Looks on the Charts After Earnings

Johnson & Johnson: How the Stock Looks on the Charts After Earnings

Experienced traders could approach the long side carefully.

The Meat and Potatoes of This Global Economic Slowdown: Market Recon

The Meat and Potatoes of This Global Economic Slowdown: Market Recon

It's centered around a few themed negatives, all forcing their own various uncertainties into free market price discovery.

IBM, Johnson & Johnson, Starbucks, Global Growth Worries- 5 Things You Must Know

IBM, Johnson & Johnson, Starbucks, Global Growth Worries- 5 Things You Must Know

U.S. stock futures fall amid warnings on global economic growth; Johnson & Johnson, IBM and Travelers report earnings Tuesday; Swiss bank UBS posts weaker-than-expected fourth-quarter earnings; Starbucks expands its delivery service.

Johnson & Johnson Reports 2018 Fourth-Quarter Results:

Johnson & Johnson Reports 2018 Fourth-Quarter Results:

2018 Fourth-Quarter Sales of $20.4 Billion increased 1.0%; EPS was $1.12

TheStreet Quant Rating: B (Buy)